Literature DB >> 34979334

Real-world adoption of FDA-approved peanut oral immunotherapy with palforzia.

Sara Patrawala1, Allison Ramsey2, Peter Capucilli2, Linh-An Tuong3, Karthik Vadamalai4, S Shahzad Mustafa5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34979334     DOI： 10.1016/j.jaip.2021.12.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice.

Authors:  Jay Portnoy; Christina E Ciaccio; Janet Beausoleil; George Du Toit; Stanley Fineman; Stephen A Tilles; June Zhang; Claire Lawrence; Mohamed Yassine; S Shahzad Mustafa
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-09       Impact factor: 3.373

Review 2.  Measuring the Impact of Food Immunotherapy on Health-Related Quality of Life in Clinical Trials.

Authors:  Melanie Lloyd; Audrey Dunn Galvin; Mimi L K Tang
Journal:  Front Allergy       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.